The Grey Zone Project: Risk-Based Classification of ABCD1 Variants in X-Linked Adrenoleukodystrophy. [PDF]
Lund TC +17 more
europepmc +1 more source
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial. [PDF]
García-Cazorla Á +25 more
europepmc +1 more source
Post-Tuberculosis Adrenal Crisis in a Young Boy: A Case Report. [PDF]
Haleem A +5 more
europepmc +1 more source
Case Report: Incidental diagnosis of cystic fibrosis via whole genome sequencing alters HSCT planning in a child with cerebral X-linked adrenoleukodystrophy. [PDF]
Sy JAC, Tan PL, Lin JB, Tay SK, Chin HL.
europepmc +1 more source
X-Linked Adrenoleukodystrophy in a Moroccan Patient: Genetic Diagnosis Leads to Presymptomatic Testing and Family Counseling. [PDF]
Mansouri M +7 more
europepmc +1 more source
Profiling of fatty acids and lipids in animal and human tissues yields new leads for disease progression biomarkers of X-linked adrenoleukodystrophy. [PDF]
Kloss A +11 more
europepmc +1 more source
Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells. [PDF]
Petrova IO, Smirnikhina SA.
europepmc +1 more source
Stem cell and gene therapies for leukodystrophies. [PDF]
Lin W, Zhang M, Zheng S, Lian Q.
europepmc +1 more source
Adult-onset cerebral X-linked adrenoleukodystrophy presenting with frontal lobe syndrome caused by a de novo <i>ABCD1</i> gene mutation (c.1415_1416delAG, p.Gln472fs*83). [PDF]
Ghosh R +4 more
europepmc +1 more source

